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Abstract
Pathogenesis is strongly dependent on microbial context, but development of probiotic therapies has neglected the impact
of ecological interactions. Dynamics among microbial communities, host immune responses, and environmental conditions
may alter the effect of probiotics in human and veterinary medicine, agriculture and aquaculture, and the proposed
treatment of emerging wildlife and zoonotic diseases such as those occurring on amphibians or vectored by mosquitoes.
Here we use a holistic measure of amphibian mucosal defenses to test the effects of probiotic treatments and to assess
disease risk under different ecological contexts. We developed a non-invasive assay for antifungal function of the skin
mucosal ecosystem (mucosome function) integrating host immune factors and the microbial community as an alternative
to pathogen exposure experiments. From approximately 8500 amphibians sampled across Europe, we compared field
infection prevalence with mucosome function against the emerging fungal pathogen Batrachochytrium dendrobatidis. Four
species were tested with laboratory exposure experiments, and a highly susceptible species, Alytes obstetricans, was treated
with a variety of temperature and microbial conditions to test the effects of probiotic therapies and environmental
conditions on mucosome function. We found that antifungal function of the amphibian skin mucosome predicts the
prevalence of infection with the fungal pathogen in natural populations, and is linked to survival in laboratory exposure
experiments. When altered by probiotic therapy, the mucosome increased antifungal capacity, while previous exposure to
the pathogen was suppressive. In culture, antifungal properties of probiotics depended strongly on immunological and
environmental context including temperature, competition, and pathogen presence. Functional changes in microbiota with
shifts in temperature provide an alternative mechanistic explanation for patterns of disease susceptibility related to climate
beyond direct impact on host or pathogen. This nonlethal management tool can be used to optimize and quickly assess the
relative benefits of probiotic therapies under different climatic, microbial, or host conditions.
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Introduction
Probiotic therapies often aim to extend or shape the immune
function of hosts by altering the symbiotic microbial community.
Probiotics are used in human and veterinary medicine, agriculture
and aquaculture, and have been proposed for treatment of
emerging wildlife diseases such as those occurring on corals and
amphibians [1,2]. Microbiota can mediate pathogenesis through a
range of mechanisms [3,4], and disease ecology studies demon-
strate that parasitic and non-parasitic microbes interact with each
other and with the host immune system such that pathogenicity is
often influenced by environmental conditions [5–8]. Thus, the
environment affects the risk of disease to individuals, populations,
and species, and assessing disease risk under changing conditions is
vital to conservation and infectious disease mitigation and can
direct the allocation of resources for most effect [9–12].
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The microbiota inhabiting skin and mucosal surfaces has a
profound impact on host health and immunity [7,13,14], and may
be predictive of risk for some diseases [15–17]. Amphibian skin is a
model system for diseases affecting vertebrate mucosa. The
mucosome, or micro-ecosystem of the mucus, as defined here
contains interdependent host factors (mucosal antibodies, antimi-
crobial peptides, lysozyme, alkaloids) and microbial-community
factors (microbiota, antibiotic metabolites). The mucosome has
various functions potentially including communication, and
predator and pathogen defense. Here, we develop a non-lethal
assay and holistic measure referred to as ‘‘mucosome function’’ to
describe the effect of amphibian skin mucus on pathogen viability.
We examine how environmental and immunological contexts may
impact the outcome of host-microbe symbioses, and how
mucosome function captures the in vivo complexity of the micro-
ecosystem and can thus accurately predict susceptibility to
infection. We focus on probiotic bacteria and fungi applied to
the skin mucosome as biocontrol agents against the emerging
amphibian disease chytridiomycosis.
Chytridiomycosis is a major cause of global amphibian
population declines and species extinctions [18,19]. The disease
is caused by the chytrid fungus Batrachochytrium dendrobatidis, or Bd,
and is strongly influenced by climatic conditions [20]. Climate-
linked changes to the entire microbiota, not just Bd, may influence
disease susceptibility [5]. Current efforts to mitigate chytridiomy-
cosis in wildlife populations have turned to bioaugmentation, or
the use of probiotic therapies [1,21]. The successful prophylactic
use of Janthinobacterium lividum was demonstrated against chytridio-
mycosis in mountain yellow-legged frogs, Rana muscosa [22].
However, when tested on the endangered Panamanian golden
frog, Atelopus zeteki, the probiotic survived briefly on the skin, but
did not protect the amphibians from disease [23]. Similarly, the
probiotic Pedobacter cryoconitis temporarily reduced infection loads of
heavily infected R. muscosa [24]. Each target host may thus require
probiotic therapy tailored to that species, population, or life-
history stage. Screening the various bacteria associated with hosts
or their environment to identify effective probiotics is challenging
[25,26]. Thus, probiotic therapies for amphibians must be
optimized, and an understanding of which candidate bacteria
can establish and persist on the host in its natural environmental
context is urgently needed.
To date, all attempts to apply probiotic therapy against
chytridiomycosis have used simple selection criteria for choosing
candidate probiotics. Selection of the most efficient probiotic is
challenging because there are hundreds of culturable phylotypes to
choose from, either from environmental sources, or more typically,
from tolerant host populations that can persist with nonlethal Bd
infections [1]. However, simple co-culture assays to determine
antifungal capacity have been insufficient to ensure probiotic
effectiveness [23,24]. Co-factors including interactions of the
probiotic with the microbial community already present on the
amphibian skin, as well as interactions with host immune defenses,
and effects of environmental conditions, may complicate the
outcome of biotherapy. Here, we experimentally test the impact of
immunological and environmental context on potential probiotic
bacteria both in vitro and in vivo. The tested conditions are
illustrative rather than comprehensive for potential environmental
conditions, community and immunological interactions. Because it
is impractical to test all potential interactions before testing
probiotics on amphibians for a disease resistance effect, we suggest
a protocol for selecting probiotics with the highest potential
benefit, and to test whether the probiotics will likely be effective in
the range of foreseeable conditions on the host. Our non-lethal
susceptibility assay of mucosome function can help assess disease
risk and treatment effects in rare amphibians including relict
populations or captive populations of endangered species intended
for reintroduction.
Typical approaches to compare species susceptibility and to
assess disease risk include pathogen exposure experiments [27], or
field surveys to compare infection prevalence and monitor disease
and population trajectories [28], or modeling environmental and
biogeographic risk factors [10,29]. Deficits of conventional
pathogen exposure experiments include lack of environmental
context when amphibians are exposed under clean laboratory
conditions. Biodiversity including microbiota and macrobiota can
influence disease outcome [30], and bacterial community diversity
is reduced through time in captivity without natural sources such
as soil for re-inoculating the skin [31]. The exposure history,
population genetics, and life-history stage of the amphibians used
in the experiment, as well as the strain and dose of the pathogen
can all affect experimental outcomes, and many threatened species
are not suitable for such experiments. In addition, growth of Bd is
often inhibited by skin microbiota of amphibians [32,33].
However, little is known about how protective microbiota differs
among host populations or regions, or how mucosome function is
altered by enrichment with potential probiotics.
Our aims in this study were (1) to develop a holistic, simple,
non-invasive, and non-lethal method to measure mucosome
function against Bd. Using this tool, we aimed (2) to test whether
mucosome function can predict Bd infection prevalence of
amphibians in the field and survival in Bd exposure experiments.
While we show that probiotics are influenced by a variety of
factors including competition, temperature, and innate immunity
when tested in vitro, we aimed (3) to use mucosome function as an
ecologically-integrated predictor of probiotic therapy effect so that
future research can test probiotic strategies for conservation and
not lose hope in the potential of probiotic therapy in the face of
immunological and ecological complexity. We provide a detailed
protocol for measuring mucosome function in File S1.
Materials and Methods
Ethics statement
Permits to conduct fieldwork were obtained from the Swiss
cantonal conservation authorities, and from Germany - German
federal licence (Rheinland-Pfalz) no. 425-104.143.0904 Struktur-
und Genehmigungsdirektion Nord, Koblenz. All animal proce-
dures were approved by the Veterinary Authority of Zurich (110/
2007 and 227/2007) and the Federal Office for the Environment.
Fieldwork conformed to standard decontamination practices to
avoid transport of pathogens between sites. All animals in
experiments were monitored daily for animal welfare and to
ameliorate suffering. During experiments, any individual demon-
strating clinical signs of disease including lethargy, abnormal skin
shedding, and loss of righting reflex were humanely euthanized. At
the end of the experiment, all animals were humanely euthanized
by overdose of tricaine methanesulfonate.
Survey of Bd infection prevalence
To compare Bd infection prevalence among species and life-
history stages, we combine previously unpublished results from
field studies in Switzerland with Bd surveys from amphibians
across Europe collated by Bd-Maps (www.bd-maps.net, accessed
September 1, 2013). In addition to data from 5939 sampled
amphibians available from Bd-maps, skin swabs were collected
from 2591 amphibians from 12 species and from 66 Bd-positive
populations from the northern parts of Switzerland and tested for
Bd between 2007 and 2009 (Table 1). Amphibians were caught by
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dip-netting and swabbed with a sterile cotton swab (Copan Italia
S.p.A., Brescia, Italy). Field material was cleaned and disinfected
before moving between different sites to avoid contamination and
spread of Bd and other pathogens. Extraction and analysis for Bd-
DNA were done following the qPCR protocol by Boyle et al. [34]
using Bd-specific primers and standards to quantify the amount of
DNA. We ran each sample twice and the PCR was repeated if the
two wells returned dissimilar results. Reactions below 1 genomic
equivalent were scored Bd-negative to avoid false positives. Mean
infection prevalence with 95% binomial confidence interval was
calculated for each species and life stage sampled, and calculated
for both Europe and Switzerland.
Bd infection prevalence predicted by skin defenses
Skin defense peptides and mucosome samples were tested
against Bd for comparison of anti-Bd activity with infection
prevalence in natural populations by logistic regression in R.
Amphibians sampled for skin peptides and mucosome function
(Table 1) were sampled in Switzerland and compared to field
infection prevalence from Switzerland and across Europe in
separate analyses. Skin peptides were collected upon induction by
subcutaneous injection of metamorphosed amphibians with 40
nmole/g body mass norepinephrine (bitartrate salt, Sigma) or
immersion of larval amphibians in 100 mM norepinephrine, and
tested for Bd growth inhibition as previously described [35,36].
Skin peptide samples from post-metamorphic amphibians only
were used in the logistic regression analyses because different
methods of peptide induction were used on larval stages.
Mucosome samples from multiple life-history stages of the same
species were included and matched to life-history stages sampled
for Bd diagnostics (Table 1). Detailed methods for measuring
mucosome function against Bd using a fluorescence assay of Bd
viability adapted from Stockwell et al. [37] (Fig. S1 in File S1) and
comparisons of mucosome function and skin peptide defenses
against Bd are presented in Supporting Information (Figs. S4, S5 in
File S1).
Survival predicted by mucosome function
To examine the relationship between mucosome function
against Bd and susceptibility to infection and subsequent survival
we performed experimental exposures to Bd on four species. All
animals were exposed to zoospores from Swiss lineage Bd TG 739
isolated from a moribund A. obstetricans in Gamlikon, Switzerland
in 2007 [38] and cryopreserved until use. Egg clutches were
obtained from P. esculentus (n = 8), B. variegata (n = 8), R. temporaria
(n = 45), and A. obstetricans (n = 13) in northern Switzerland or
southern Germany. Rana temporaria were raised in outdoor
mesocosms through metamorphosis before experimental exposure
of metamorphs to Bd (N = 92 exposed, 94 control). Other species
were exposed to Bd as tadpoles (N = 80 exposed, 40 control per
species). All animals were kept in the same laboratory at 19uC
during the experiments. We measured the proportion of infected
metamorphs by qPCR, and determined relative survival (survival
of infected/survival of uninfected controls) at the end of the
experiments (50–90 d after metamorphosis). Kaplan Meier curves
are presented in the Supporting Information for each species. We
examined the relationship between mucosome function against Bd
and relative survival and proportion infected using logistic
regression analyses in R.
Host ecological context and skin defenses
The in vivo effects of ambient temperature and skin microbiota
on mucosome function against Bd and skin peptide defenses were
tested on a focal amphibian species, A. obstetricans. In Europe, the
common midwife toad, A. obstetricans, is a species of conservation
concern [39] and is particularly sensitive to Bd early in life-history
[40]. Host-associated bacteria and fungi were surveyed by
culturing from populations of midwife toads near Basel, Switzer-
land in May, 2009, including samples from 19 adults, 32 larvae,
and 9 egg clutches. Although many diverse antifungal bacteria
have been described in association with skin of some amphibian
hosts [32,33], we chose eleven bacterial residents isolated from A.
obstetricans for the environmental context experiments described
below based on potency against Bd in culture and high prevalence
in the populations sampled (L. Davis, unpublished). Two bacterial
isolates with high in vitro potency against Bd and the ability to
withstand host skin defense peptides, and one fungal isolate, were
chosen for applications on recently metamorphosed A. obstetricans.
All metamorphs used in the study were raised in captivity from
wild-caught tadpoles that were naturally exposed to the fungus in
their pond of origin, near Zunzgen, Switzerland, but negative for
Bd by qPCR at the time of the experiment. Toadlets were of
similar size (mean6SD: 2.160.3 g; ANOVA F5 = 1.179,
P = 0.332) and treated at the same time with one exception.
Toadlets in the Bd-exposure group were exposed to Bd approx-
imately 2 months prior to the microbial exposure treatments, and
the toadlets were smaller (1.560.3 g), and no longer infected at the
time of sampling based on qPCR.
We treated recently metamorphosed common midwife toads,
Alytes obstetricans (N = 70: 10 per treatment group, 7 treatments), by
housing them individually at 5uC, 18uC, or 25uC with no microbes
added, or at 18uC with exposure to Bd zoospores (8.56106
zoospores of global panzootic lineage isolated from a Bufo bufo in
the UK [38]), a probiotic fungus Penicillium expansum, or a probiotic
bacterium P. fluorescens or F. johnsoniae. Toadlets were bathed
individually for one hour in water containing the microbes and
after 2 weeks, toadlets from all treatments were sampled on the
same day for mucosome function and subsequently skin peptides,
sampled as described above.
Temperature, competition of probiotic strains, and
co-culture with Bd
To determine the effects of competitive interactions and
temperature on probiotic potential, 11 common host-associated
isolates were chosen. These included two isolates of Serratia
plymuthica and one isolate of Janthinobacterium lividum from egg
clutches of midwife toads, three isolates of Flavobacterium johnsoniae
and five species of Pseudomonas isolated from the skin of adults.
Based on 16S rRNA gene sequences, all 11 isolates were
considered unique operational taxonomic units (OTUs) at 99%,
but clustered into 7 OTUs at 97% similarity as determined by the
UCLUST algorithm in QIIME. The 16S rRNA gene sequences of
all isolates were deposited in the European Nucleotide Archive
(Table S1 in File S1).
In one set of experiments, bacterial isolates were freshly grown
at 18uC on RIIA agar media supplemented with 1% tryptone then
transferred to experimental conditions. Bacteria and Bd (Swiss
isolate TG 739) readily grew on the same media. Plate
experiments were performed in duplicate. Both isolates of Serratia
plymuthica were grown separately at 18 and 25uC, or at 18uC on
media inoculated with Bd and allowed to dry before streaking the
bacteria. Two isolates of F. johnsoniae were grown separately or
combined on media inoculated with Bd, and grown at 18uC. When
combined, each isolate was streaked across the entire plate. Three
Pseudomonas isolates were grown either separately, combined, or
combined on media inoculated with Bd, and grown at 18uC.
Control plates of sterile media or Bd-only were also tested. All
plates were incubated for 3 days, and then rinsed with 2 ml sterile
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Mili-Q water. Rinse water was then filtered through a 0.22 mm
syringe filter.
Bacteria were also grown in liquid RIIA media for 4 d at 14, 19,
and 22uC, and metabolites filtered as above. Metabolites from
liquid cultures were added to Bd zoospores (Global panzootic
lineage VMV 813 from a bullfrog, Lithobates catesbeianus tadpole) to
test for inhibitory effects on pathogen growth. To determine the
effect of bacterial filtrate on Bd growth, Bd zoospores were
harvested in 1% tryptone and counted under a hemocytometer.
Wells of a 96-well plate were inoculated with 50 ml zoospores at
86106 zoospores per ml. Then, 50 ml of filtrate (or filtrate diluted
1:10) from each of the experimental or control plates, or liquid
cultures, was added to the wells in replicates of four. In addition, 6
positive control wells contained Bd and 50 ml sterile water or RIIA
media, and 6 negative control wells contained heat-killed Bd and
50 ml sterile water or RIIA media. The change in optical density
measured at 490 nm absorbance over 7 days growth at 19uC was
recorded using a Victor3 multilabel plate reader (PerkinElmer).
Standard statistical testing was carried out in IBM SPSS Statistics
22. Significant Bd growth inhibition (or enhancement) caused by
bacterial filtrate was determined by t-test, and a repeatable result
(Table S2 in File S1). Percent inhibition depended on filtrate dose
(see Results) and was not considered comparable among bacterial
isolates.
Effects of host skin peptides and Bd metabolites on
probiotics in culture
To test for the response of bacterial growth upon culture with
either Bd filtrate or host skin peptides, bacteria were grown in
RIIA liquid media on 96 well plates. Supernatant from a 2-week
old culture of Bd (type isolate JEL 197) growing in 0.5% tyrptone
was filtered through a 0.22 mm syringe filter. An equal volume of
Bd filtrate or sterile media was added to bacterial cultures. To test
effects of peptides, we added an equal volume of sterile water or
natural mixtures of partially-purified skin peptides from A.
obstetricans metamorphs at a final concentration of 100 mg/ml in
water. Growth after 48 hr was measured as change in optical
density measured at 480 nm. Differences between experimental
and control bacterial growth were tested by t-tests using a
Bonferroni correction for multiple comparisons.
Results
Survey of Bd infection prevalence
Surveys of approximately 8500 amphibians (http://www.
bd-maps.net/; this study) at different life-history stages for Bd
infection based on qPCR indicated high prevalence in larval
midwife toads, A. obstetricans (45% infected in Switzerland) and
aquatic adult newts Ichthyosaura alpestris (26%), and Lissotriton vulgaris
(27%). Low infection prevalence (,5%) was detected in popula-
tions of adult A. obstetricans, Bufo bufo, Rana temporaria, and Hyla
arborea (Table 1, Fig. 1).
Bd infection prevalence predicted by skin defenses
We examined two non-lethal measures of susceptibility to
infection in pathogen-free Swiss amphibians acclimated to
laboratory conditions. These included testing Bd growth or
viability upon exposure to natural mixtures of partially purified
skin defense peptides, and a holistic functional measure of the skin
mucosal ecosystem (mucosome function) including ambient skin
defenses: peptides, alkaloids, lysozymes, mucosal antibodies,
microbiota and microbial metabolites [41]. Both antifungal skin
peptides and mucosome function were correlated with infection
prevalence in natural populations across Europe (Fig. 1a,c) and
within Switzerland (Fig. 1b,d). Prevalence of infection with Bd
decreased with peptide efficiency (Fig. 1c,d, logistic regressions:
Europe, P = 0.0015; Switzerland, P = 0.0079). While induced
peptide defenses stored in granular glands were measured here,
ambient peptides (not induced by norepinephrine) are a natural
component of the mucosome [42,43]. Mucosome function was
tightly correlated to Bd prevalence in natural populations of Swiss
amphibians (Fig. 1b, P,0.0001) and in amphibians across Europe
(Fig. 1a, P = 0.0020). The odds ratios of Bd colonization in Swiss
amphibians was 1.950 (Europe, 2.969) with each unit change in
mucosome function, and 0.839 (Europe, 0.811) with each unit
decrease in skin peptide efficiency. Correlations of mucosome
function and induced skin peptide efficiency are presented in
Figure S4 in File S1 and suggest that both host and microbial
factors contribute to mucosome function against Bd.
Survival predicted by mucosome function
Pathogen exposure experiments were conducted on four host
species with a Swiss isolate of Bd, and relative survival post-
metamorphosis of infected tadpoles differed among species (%
relative survival, mean6SD days survived): A. obstetricans (0%,
24617.5 d), Bombina variegata (39.0%, 32623.9 d), and Pelophylax
esculentus (30.4%, 12612.8 d; Fig. S2 in File S1). Relative survival
of recently metamorphosed Rana temporaria exposed to Bd was
100% (Fig. S3 in File S1), and no colonization by Bd was detected
by qPCR (n = 92). Success of Bd colonization of tadpoles also
differed among species (Pearson x23 = 13.102, P = 0.004): A.
obstetricans (13.9% infected, n = 36), B. variegata (10.7%, n = 75),
and P. esculentus (7.9%, n = 76). Mucosome function predicted
survival (logistic regression, P,0.0001; Fig. 2a) and infection with
Bd in these species (P = 0.0106; Fig. 2b). The odds of infection
increased by 1.751 with each unit change in mucosome function,
and the odds of survival decreased by 0.0454.
Host ecological context and skin defenses
Midwife toads, A. obstetricans, were treated with various
temperature and probiotic therapies and tested for mucosome
function. Host context significantly affected mucosome permis-
siveness or lethality towards Bd (Fig. 3a; ANOVA, F6 = 41.606, P,
0.001). Bd viability was similar following incubation with
mucosome samples from toads at temperatures ranging from 5–
25uC. Mucosome samples from toads previously exposed to Bd
were least effective at killing Bd zoospores, while those from toads
treated with probiotics Flavobacterium johnsoniae and Penicillium
expansum were most effective at killing zoospores (Fig. 3a). While
Pseudomonas in general, and the P. fluorescens isolate (76.5c) used in
this study were often effective at inhibiting Bd in co-culture and
produced antifungal metabolites across a range of temperatures
ideal for Bd growth (Fig. 4a, Table S2 in File S1), there was no
significant benefit of this probiotic when applied on hosts in terms
of increasing mucosome function and reducing Bd viability
(Fig. 3a).
Because one significant antimicrobial component of A. obste-
tricans skin mucus is antimicrobial peptides (AMPs) [44], we
collected peptide skin secretions, quantified them per surface area
of the toads and measured their ability to inhibit Bd growth at a
standardized concentration of 100 mg/ml. On average, toads
produced 0.25 mg peptide per cm2 surface area, and at 100 mg/ml
these peptides inhibited Bd growth by 48.7%. These values did not
differ significantly among treatment groups, nor did a combined
measure of skin peptide effectiveness against Bd (% * mg/cm2,
Fig. 3b; Kruskal-Wallis tests, P ’s.0.05). Thus, skin peptides stored
in granular glands were not significantly affected by the 2-week
temperature and microbe treatments including previous exposure
Mucosome Function Predicts Disease Risk
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to Bd. There was not a significant correlation between peptide
effectiveness and mucosome function against Bd (Fig. S5 in File S1;
Pearson, x2 =20.102, P = 0.827). Zoospore viability after expo-
sure to mucosome samples was significantly higher in the Bd-
exposure treatment compared to other treatments (Fig. 3a).
However, skin peptides induced from hosts in the Bd-exposure
treatment were effective at inhibiting Bd growth, and not
significantly different than peptides from toads in other treatments
(Fig. 3b).
Temperature, competition of probiotic strains, and
co-culture with Bd
Environmental conditions affected the capacity of probiotic
bacteria to inhibit the fungal pathogen Bd (Table S2 in File S1).
Two Serratia plymuthica isolates (isolates 27 and 28) were capable of
inhibiting Bd growth when incubated at 18uC. Isolate 27 was
inhibitory under all tested conditions: 18uC, 25uC, and 18uC co-
cultured with Bd. Isolate 28 significantly enhanced Bd growth at
25uC, and was neither enhancing nor inhibitory at 18uC when co-
cultured with Bd (Fig. 4c, Table S2 in File S1). A dose-response of
Bd growth inhibition was found such that filtrate diluted 1/10 was
Figure 1. Infection prevalence (mean, 95% binomial CI) of amphibians sampled across Europe and within Switzerland predicted by
mucosome function and skin defense peptide activity against Batrachochytrium dendrobatidis (Bd) zoospores. Mucosome function
(mean, SE) indicates Bd viability after a 1 hr exposure to amphibian mucus (a,b) and units represent green:red fluorescence. Peptide efficiency (mean,
SE) indicates quantity of natural mixtures of skin peptides induced from granular glands multiplied by activity of a standard concentration of peptides
against Bd zoospore growth. Only post-metamorphic amphibians sampled upon subcutaneous injection with norepinephrine are plotted in (c) and
(d). Amphibian skin mucosome function is a better predictor of infection prevalence than induced skin peptide efficiency (logistic regression, see
text). Summary data for all species and life-history stages are presented in Table 1.
doi:10.1371/journal.pone.0096375.g001
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significantly less inhibitory than undiluted filtrate (paired t-test,
t35 = 9.836, P,0.001), and filtrate from control plates with or
without Bd significantly enhanced Bd growth (Table S2 in File S1).
Testing metabolites of the bacteria growing at 14, 19, and 22uC in
liquid culture against the global panzootic lineage of Bd showed
similar results including a dose-response (Fig. 4a,b, paired t-test,
t31 =210.607, P,0.001). In several cases, Bd growth was
enhanced with addition of diluted bacterial metabolites in
comparison to positive control growth with RIIA media only
(.100%, Fig. 4b). Most cultures were more inhibitory of Bd at the
lower temperatures, except for J. lividum, (isolate 77.5b) which was
most inhibitory at 22uC (Fig. 4a,b).
While all bacteria were unique based on 16S rRNA gene
sequencing when clustered at 99% similarity, probiotic physiology
and function against Bd did not always correspond to OTU
clustering at 97% similarity (Table S1 in File S1). In other words,
bacterial isolates considered to be the same ‘‘species’’ based on 16S
rRNA could have different antifungal function. Here, only one of
two Flavobacterium johnsoniae isolates inhibited Bd growth. When
grown together, the filtrate remained inhibitory. However, when
grown together and co-cultured with Bd, the filtrate was no longer
inhibitory. Three Pseudomonas isolates were capable of inhibiting Bd
growth, and were inhibitory when combined with or without co-
culture with Bd. The above mentioned growth inhibition of Bd
caused by bacterial filtrate was significantly different from control
bacterial growth with water only added (independent t-tests, P’s,
0.05 and replicated result; all data shown in Table S2 in File S1).
These conditions represent infected or uninfected hosts and are
illustrative rather than comprehensive of all possible environmen-
tal conditions and competitive interactions.
Effects of host skin peptides and Bd metabolites on
probiotics in culture
Amphibian skin defense peptides may regulate the skin
microbiota. We found that natural mixtures of skin peptides from
A. obstetricans at a concentration of 100 mg/ml significantly
inhibited growth of Pseudomonas migulae (73b1) and significantly
enhanced growth of P. filiscindens (73c1), Flavobacterium johnsoniae
(70d1), and Janthinobacterium lividum (76.5c; t-test, Bonferroni
corrected P’s,0.05; Fig. S6 in File S1).
We tested for a direct effect of Bd metabolites on bacterial
growth, and found that filtrate from two-week old cultures of Bd in
0.5% tryptone significantly inhibited the growth of Serratia
plymuthica (5/27b2, 5/28a3), F. johnsoniae (81a1, 70d1), and P.
filiscindens (73c1), while significantly enhancing the growth of J.
lividum (77.5b1; t-test, Bonferroni corrected P’s,0.05; Fig. S6 in
File S1).
Discussion
We found that a holistic measure of mucosome function against
Bd is predictive of infection risk in natural populations of
amphibians and survival in laboratory exposure experiments.
While induced antimicrobial peptides may explain some variation
in infection risk (Fig. 1b,d), mucosome function can be altered
through probiotic therapy (Fig. 3a), and thus microbial commu-
nities play a major role in determining susceptibility to infection
with Bd. In particular, tadpoles of the endangered midwife toad, A.
obstetricans may be most at risk of both infection and subsequent
disease-induced mortality upon metamorphosis (Fig. 2), even
though adult toads are well protected by the mucosome and
perhaps resistant to colonization with Bd. Similarly, the common
frog R. temporaria has strong mucosome activity against Bd, shows
Bd colonization resistance, but has relatively poor skin defense
peptides. This suggests that this common species has protective
microbial communities. Adaptive defenses are not suspected
because frogs were raised from eggs and had no history of
exposure to Bd.
In this study, we provide several striking examples showing that
probiotic capacity depends on immunological and environmental
context. These examples lead to recommendations for choosing
probiotics based on predictable host conditions. Temperature is
known to influence amphibian host immune function [41] and
Figure 2. Relative survival (95% binomial CI; a) and Proportion
of infected frogs (95% binomial CI; b) predicted by Mucosome
function. Post-metamorphosis survival was measured from four Swiss
amphibian species after exposure to zoospores of a Swiss Bd isolate, TG
739. Survival curves for each species are presented in Supporting
Information (Figs. S2, S3 in File S1) and relative survival was calculated
as the proportion of infected frogs surviving/proportion of unexposed
control frogs surviving. Alytes obstetricans showed the highest infection
and mortality, and Rana temporaria the lowest, with Bombina variegata
and Pelophylax esculentus intermediate. All frogs were raised in captivity
from egg clutches and had no history of natural exposure to Bd.
Mucosome function (mean, SE) indicates Bd viability after exposure to
amphibian mucus and is a significant predictor of both survival
(binomial logistic regressions, P,0.0001) and infection prevalence
(P = 0.0106).
doi:10.1371/journal.pone.0096375.g002
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bacterial growth, metabolism, pigment and antibiotic production
[45]. However, it was surprising that a shift from 18 to 25uC, a
typical natural range for midwife toads, caused a common
bacterial symbiont of the eggs and skin, Serratia plymuthica, to
change from inhibiting Bd to enhancing Bd growth (Fig. 4c).
Testing metabolites of the bacteria growing at 14, 19, and 22uC in
liquid culture against the global panzootic lineage of Bd showed
similar results (Fig. 4b). Functional changes in probiotic activity
with shifts in temperature have not previously been reported. Our
results provide an alternative mechanistic explanation for patterns
of susceptibility related to climate, which have previously been
limited to empirical observation and pathogen-centered effects
[46–49].
The microbial interactions we tested also altered antifungal
effects relative to what would be predicted from individual isolates.
For example, co-culture of Flavobacterium johnsoniae with Bd caused
cultures of the bacterium that normally produce antifungal
metabolites to switch off antifungal activity: when grown together
with Bd, F. johnsoniae filtrate was benign, and indeed Bd filtrate
inhibited the growth of two out of three F. johnsoniae isolates (Fig.
Figure 3. Temperature and probiotic treatments of recently metamorphosed midwife toads, A. obstetricans, influence skin
mucosome function (a) but not induced skin peptide defenses (b). (a) Mucosome function indicates B. dendrobatidis (Bd) viability after
exposure to amphibian mucus quantified by green: red fluorescence. Significantly different subsets are indicated by letters above bars (Tukey post-
hoc test). Bd zoospore viability was reduced after exposure to mucus from frogs treated with the bacterium F. johnsoniae and the fungus P.
expansum, and zoospore viability was highest after exposure to mucus from toads previously exposed to Bd. (b) Skin peptide effectiveness against Bd
did not differ significantly among treatments (ANOVA, F6 = 0.952, P=0.466).
doi:10.1371/journal.pone.0096375.g003
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S6 in File S1). Co-evolution of Bd and amphibian hosts is a
postulated driver of pathogenicity factors including compounds
suppressing host immune defenses [43,50,51]. These factors may
extend to inhibiting certain antifungal symbionts or altering their
function.
Myriad microbial and immune interactions occur once
probiotics are added to living hosts. Thus, testing probiotics in
vivo is critical for testing the intended antifungal effect of probiotic
therapy under realistic environmental conditions. We found that
previous exposure to Bd may have a negative effect on host
immunity or the ability of the mucosome to kill zoospores (Fig. 3A).
This result is consistent with a study on Australia green-eyed tree
frogs, Litoria serratia, showing inhibition of ambient skin peptides
with Bd infection but no inhibition of inducible stored skin peptides
[43]. Because stored skin defense peptides can have potent activity
against Bd, yet not be active on the skin, induced skin peptides may
not accurately predict infection susceptibility. This mystery of how
seemingly well-defended species can be affected by chytridiomy-
cosis [52] deserves careful study on the conditions under which
host skin defense peptides are activated. Induced skin defense
peptides were previously used to predict disease susceptibility in
Panama [11] and New Zealand [53]. In Panama, most species had
weak peptide defenses and declined after disease emergence while
only two species had strong peptide defenses against Bd compared
to reference species of known disease resistance. Of these two
species, the one with the highest levels of skin peptide defenses
persisted at the field site (Espadarana prosoblepon) [54], and the other
species (Agalychnis lemur) disappeared, but a relict population has
been detected nearby (Julie Ray, pers. comm.). In New Zealand,
all native species demonstrated high levels of skin peptide defenses
and appear to resist chytridiomycosis [53], although populations
are in decline [55].
We found that a bacterium F. johnsoniae and a fungal probiotic P.
expansum can increase the Bd killing function of the mucosome. The
bacterium P. fluorescens did not show this effect. Because host AMPs
did not appear to be affected by these treatments (Fig. 3B), the
observed effects are most likely caused by antifungal metabolites
produced by the microbes growing on the amphibian skin [56].
Upregulation of host mucosal immunity excluding AMPs is an
untested alternative mechanism, and potentially a beneficial host
response to probiotics. A non-responsive immune system when
given probiotics may be preferred from a conservation manage-
ment standpoint in order for the probiotics to colonize the host,
establish within the microbiota and persist. However, this in not
necessarily common and immune stimulation in response to
probiotics occurs in other systems [57,58].
An ideal probiotic would produce metabolites that inhibit Bd
growth as shown above, and also be uninhibited by host skin
defense peptides. A literature review demonstrates that skin
peptides can inhibit the growth of some bacteria, but not others,
and suggests that skin defense peptides may be critical in
structuring the symbiont community on amphibian skin [52].
Rollins-Smith et al. [35] showed that Aeromonas hydrophila, a
common resident on amphibian skin and also an opportunistic
pathogen, could tolerate high levels of host antimicrobial peptides.
This organism shows antifungal characteristics including activity
against Bd growth [33]. The ability of extracellular products of A.
hydrophila to inhibit amphibian antimicrobial peptides indicates a
co-evolutionary relationship between host and symbionts [59]. In
addition, Pseudomonas mirabilis and Serratia liquefaciens were found to
be resistant to antimicrobial peptides from several host frog species
[60]. Here we used probiotics that largely resisted low concentra-
tions of natural mixtures of host defense peptides (Fig. S6 in File
S1). Thus, to increase the likelihood of probiotic establishment, use
of probiotics with a co-evolutionary relationship with the target
host may be advantageous.
While easily cultured, the isolates tested here may not be
dominant community members based on culture-independent
analyses [31,61,62]. Therefore, future studies will benefit by
examining the effects of probiotic treatments on the natural
microbial communities on host amphibians using culture-inde-
pendent techniques such as next-generation sequencing. While
community interactions are difficult to test in vitro and before
probiotics are applied to a host, our results affirm that testing
probiotics under certain foreseeable contexts may increase the
pace of biotherapy development.
Because potential probiotics that inhibit the growth of Bd only
do so under certain conditions, we recommend the following
screening criteria (Fig. 5): (1) Candidates for probiotic develop-
ment should be chosen from among the culturable microbiota
locally present on tolerant hosts or populations that are able to
persist with Bd [32,33]. (2) Candidates should have the capacity to
inhibit Bd growth when grown in isolation, in co-culture with Bd,
and in an environmental context relevant to the amphibian life-
cycle, and (3) the ability to resist immune defenses on host skin,
establish within the microbiota, and contribute to antifungal
defenses in vivo. Resistance to mucosal immune defenses may be
critical for establishment within the microbial community associ-
ated with the skin, and critical for long-term persistence. Some
symbionts appear to be assisted in surviving on the host by thriving
on skin mucosal products. Mucosal oligosaccharides, for example,
differ among hosts and life-history stages, and may be a selective
force in structuring the microbiota [63,64]. Amphibian skin
provides a useful model of host-microbiota interactions to better
understand mechanisms of microbial community assembly and
maintenance within vertebrate mucosa. Indeed, these mechanisms
underlie strategies to promote human health by manipulating
microbial communities - a long-term goal of the Human
Microbiome Project [7,65].
While screening for candidate probiotics, some beneficial
organisms may be inadvertently discarded based on tests of
bacterial filtrate on Bd growth. Microbes producing antifungal
metabolites such as bacteriocins [66] or small molecule antibiotics
[56,67] will be detected by this method. However, microbes may
also compete directly for space or resources, and may exclude
pathogenic fungi by other mechanisms [26,68]. Furthermore,
microbial secondary metabolites such as prodiginines produced by
Serratia spp. can be immunosuppressive [67]. Probiotics may
strongly influence host immunity through interactions with host
Toll-like receptors or NOD-like receptors, or through interactions
Figure 4. Environmental context determines antifungal capacity of probiotics. Tested temperatures (14, 19, 22uC) significantly affected the
production of bacterial metabolites in liquid media that could inhibit B. dendrobatidis (Bd; GPL isolate VMV 813) zoospore growth in a dose-
dependent fashion (a = full strength metabolites, b = 1:10 dilution). * indicates that Bd growth differed among metabolite temperature treatments
(ANOVA, Bonferroni-corrected P’s,0.05). (c) Representative replicates are shown of two isolates of Serratia plymuthica isolated from egg clutches of
common midwife toads, Alytes obstetricans, grown on solid media under different temperature conditions. Filtrate from isolate 27 always inhibited
growth of Bd, but filtrate from isolate 28 inhibited Bd growth at 18uC, and enhanced Bd growth at 25uC. Filtrate from sterile media (R2A agar
supplemented with 1% tryptone) caused enhanced growth of Bd. Note that colony color can be an indication of antifungal metabolites such as
prodiginines from red Serratia spp. [45,67], but are produced only under certain growth conditions.
doi:10.1371/journal.pone.0096375.g004
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with epithelial cells and immune system cells modulating both
local and systemic immune responses [69]. The immunomodula-
tory effect of probiotics cannot be tested with in vitro Bd growth
assays and host trials are necessary to test for these emergent
properties of probiotics.
Antimicrobial peptides and a range of other defenses protect
amphibian skin by synergizing or interacting with microbes
[41,70]. Thus, a better indication of antifungal effect of probiotics
was obtained by testing the mucosome directly on zoospore
viability. In vitro screening cannot incorporate every factor and
eventually in vivo trials, both in the lab and under natural
conditions are necessary to determine if an overall health benefit is
provided. However, beginning with a probiotic that is not likely to
become an opportunistic pathogen with changing climatic
conditions may be a consideration. Transmissible probiotics would
aid disease control at the population level [33], and if able to
persist through metamorphosis when applied to tadpoles, disease
presentation at this critical developmental stage could be avoided
for A. obstetricans and other susceptible amphibians [40]. Addition-
ally, Bd metabolites are known to be toxic to amphibian
lymphocytes [50], and in this study were toxic to certain bacteria
such as Serratia plymuthica (Fig. S6 in File S1), perhaps prohibiting
the use of certain probiotics intended as remedial biotherapy for
infected individuals. The potential for negative biodiversity-
function relationships, especially among mixtures of closely related
bacteria, cautions against the use of probiotic mixtures that may
cause interference competition and reduce host protection [71].
Further refinements to the probiotic screening and discovery
process will incorporate next-generation sequencing analyses to
target rare or as yet uncultured microbes of interest, and testing
microbial consortia that appear linked to disease resistance
function. Measuring the effectiveness of applied probiotics is a
second step in managing disease risk.
No previous studies have attempted to relate skin microbiota or
a holistic measure of skin defense function against Bd with disease
susceptibility. Given the extreme complexity of the skin micro-
ecosystem and interactions described above, the holistic measure
of mucosome function presents a significant advance in our
capacity to predict relative disease susceptibility, and to measure
the success of managed treatments without resorting to infection
trials. Here, we examined overall prevalence of infection in
Switzerland and Europe and test for correlations at these broad
scales with innate defenses from selected life-stages and species
(Fig. 1). We found a very strong correlation between mucosome
function against Bd and infection prevalence in the field and upon
experimental exposure. Since Bd-naı¨ve amphibians were sampled
for mucosome function, adaptive immunity such as mucosal
antibodies is not indicated and antifungal function can be
attributed primarily to innate defenses including the microbiota.
Indeed, altering the microbiota through probiotic treatments
affected mucosome function against Bd. In addition to assessing
infection risk in natural amphibian assemblages, mucosome
functional assays can now be used to assess risk in relict
populations or in captive colonies slated for reintroduction. While
the efficacies of human probiotics are under scrutiny [2],
quantifying the effectiveness of amphibian probiotic treatments
under scenarios of changing environmental conditions is a tangible
goal.
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